These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7602482)

  • 21. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study.
    Haq A; Michniak-Kohn B
    Drug Deliv; 2018 Nov; 25(1):1943-1949. PubMed ID: 30463442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
    Mutalik S; Parekh HS; Davies NM; Udupa N
    Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
    Hu Y; Wu YY; Xia XJ; Wu Z; Liang WQ; Gao JQ
    Drug Deliv; 2011 Jan; 18(1):84-9. PubMed ID: 20939674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
    Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
    Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles.
    Aungst BJ; Blake JA; Rogers NJ; Hussain MA
    J Pharm Sci; 1990 Dec; 79(12):1072-6. PubMed ID: 2079653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog.
    Bonhage MR; Chilcoat CD; Li Q; Melendez V; Flournoy WS
    J Vet Pharmacol Ther; 2009 Apr; 32(2):146-53. PubMed ID: 19290944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal delivery of zalcitabine: in vitro skin permeation study.
    Kim DD; Chien YW
    AIDS; 1995 Dec; 9(12):1331-6. PubMed ID: 8605052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model.
    Koyama Y; Bando H; Yamashita F; Takakura Y; Sezaki H; Hashida M
    Pharm Res; 1994 Mar; 11(3):377-83. PubMed ID: 8008702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
    Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
    da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
    Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced transdermal drug delivery of zaltoprofen using a novel formulation.
    Baek JS; Lim JH; Kang JS; Shin SC; Jung SH; Cho CW
    Int J Pharm; 2013 Sep; 453(2):358-62. PubMed ID: 23747435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
    Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y
    J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial molal volumes and solubilities of physostigmine in isopropanol:isopropyl myristate solvents in relation to skin penetrability.
    Pardo A; Shiri Y; Cohen S
    J Pharm Sci; 1991 Jun; 80(6):567-72. PubMed ID: 1941550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
    Panchagnula R; Desu H; Jain A; Khandavilli S
    Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
    Choi A; Gang H; Chun I; Gwak H
    Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers.
    Zhang YT; Wu ZH; Zhang K; Zhao JH; Ye BN; Feng NP
    J Pharm Sci; 2014 Nov; 103(11):3602-3610. PubMed ID: 25187419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives.
    Trimble JO; Light B
    Int J Pharm Compd; 2017; 21(6):530-535. PubMed ID: 29220342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.